2. Outline
• Brief History
• Rationale
• Description Contents of Minilab
• Application
• Conclusion
• Acknowledgement
• References
3. Brief History
• Developed by Merck Germany, Global Pharma
Health Fund, 1996
• Richard W.O. Jähnke PhD in Pharmaceutical
formulations
• Targeting Low income countries Fight against
SSFFC medicines
• Over 500 minilabs supplied 80+ countries
6. Three levels approach to QC of
Medicines
Level 3:
Compendial/validated
tests
Level 2: Basic
analytical
tests
Level 1:
Physical and
Visual
inspection
Source: Three level quality approach on the
quality of medicines, USPC. 2016
7. Contents: MiniLab
• 60-90 reference drug standards based on WHO
EM Model List
– 23 antimicrobials
– 12 antimalarials
– 13 anti-tb
– 3 antihelminthic
– 6 cardiovascular drugs
– 9 antiasthmatic, anti allergics, analgesics
– 6 others
• 9 optional items categories: ARV, antiTB, antiviral
9. Contents: Mini Lab
• TLC equipment
• Protective case:
– 83 x 52 x 29 cm
– 25 kg
• Starter Kit chemicals
– 22-27 boxes
– 25kg
10. Technical details Mini Lab
• Storage: Compatible- tropics
– Avoid direct sunlight
• Shelf life:
– 2 years secondary reference standards
– 5 years for reagents and solvents (opened)
• Installation: out/indoors, well ventilated
areas >indoors, running water
11. Application of Mini Lab
• Detection of falsified and substandard
medicines
• Public drug procurements
• Consumer protection institutions
• Hospitals
• Scientific societies
• Medicines regulation authorities
12. Conclusion
• GPHF MiniLab
– Focus: essential medicines
– Medicines used in developing countries
– Priority diseases
– e.g. Diseases affecting Mother & Child
• Verify the quality of medicines accurately at a
low cost and protect patients consuming
substandard, counterfeit medicines
Substandard, spurious, falsely labelled, falsified and counterfeit
Disintegration tests. 37degrees 30 minutes> Major defect if tablet dn disintegrate= dn pass this test.
Semi quantitative content evaluation means no false negatives